Headline
The latest stories from AHA Today.
Sens. Susan Collins, R-Maine, and Tina Smith, D-Minn., and Reps. Paul Tonko, D-N.Y., and Bill Huizenga, R-Mich., have introduced the Medicare Mental Health Inpatient Equity Act (S. 3061/H.R. 5674), AHA-supported legislation that would eliminate the Medicare program’s 190-day lifetime limit on…
Microsoft on Sunday posted an update on the latest activity by Nobelium, a Russian nation-state actor behind cyberattacks on SolarWinds customers in 2020.
The House Energy and Commerce Subcommittee on Health held a hearing on a number of bills to bolster the health care workforce, including the AHA-supported Dr. Lorna Breen Health Care Provider Protection Act (H.R. 1667).
A recent study published in JAMA Health Forum that examines CARES Act Provider Relief Funds allocated to health care providers misses the point of those payments and makes arbitrary choices about which payments to include, writes Ashley Thompson, AHA senior vice president for public policy analysis…
The Equal Employment Opportunity Commission posted updated and expanded technical assistance related to the COVID-19 pandemic, addressing questions about religious objections to employer COVID-19 vaccine requirements and how they interact with federal Equal Employment Opportunity laws.
The Nebraska Hospital Association named as its president, effective Dec. 6, Jeremy Nordquist, who currently serves as government affairs director for Nebraska Medicine and has 20 years’ experience in advocacy at the state and federal level. Laura Redoutey, NHA president since 2000, will retire Dec…
Starting today, consumers can preview 2022 health plans and prices at the federally facilitated Health Insurance Marketplace. Open enrollment for 2022 Marketplace plans begins Nov. 1 and runs through Jan. 15.
The National Institutes of Health will use $70 million from the American Rescue Plan Act for a program to speed development of accurate and reliable over-the-counter tests for COVID-19, the Department of Health and Human Services announced.
Moderna released topline results from its ongoing phase 2/3 clinical trial of its COVID-19 vaccine for children age 6 through 11, revealing a strong antibody response against SARS-CoV-2.
The Centers for Medicare & Medicaid Services released Medicare Part B billing codes and payment allowances for reporting and administering single booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines to eligible adults as authorized Oct. 22 by the Food and Drug Administration…